Brooks Laboratories Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 26.25 Cr
as on 16-11-2024
- Company Age 23 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 31.58 Cr
as on 16-11-2024
- Satisfied Charges ₹ 96.35 Cr
as on 16-11-2024
- Revenue -28.58%
(FY 2023)
- Profit -1329.91%
(FY 2023)
- Ebitda -425.75%
(FY 2023)
- Net Worth -12.65%
(FY 2023)
- Total Assets -10.66%
(FY 2023)
About Brooks Laboratories
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 533543 and on the National Stock Exchange(NSE) under BROOKS.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 26.25 Cr.
The company currently has active open charges totaling ₹31.58 Cr. The company has closed loans amounting to ₹96.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Brooks Laboratories Limited India is Prashant Rathi as CFO. Bhushan Rana, Usha Singh, Manav Mahajan, and Three other members serve as directors at the Company.
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Brooks Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Rathi | CFO | 24-Jul-2020 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhushan Rana  | Whole-Time Director | 23-Aug-2023 | Current |
| Usha Singh | Director | 26-Aug-2024 | Current |
| Manav Mahajan | Director | 19-Oct-2024 | Current |
| Jitendrapratap Singh | Whole-Time Director | 23-Nov-2022 | Current |
| Lalit Mahajan | Director | 26-Aug-2024 | Current |
| Durga Maity | Whole-Time Director | 07-Jul-2023 | Current |
Financial Performance of Brooks Laboratories.
Brooks Laboratories Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.58% decrease. The company also saw a substantial fall in profitability, with a 1329.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brooks Laboratories?
In 2023, Brooks Laboratories had a promoter holding of 66.41% and a public holding of 33.59%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹31.58 Cr
₹96.35 Cr
Charges Breakdown by Lending Institutions
- Indian Bank : 19.39 Cr
- Others : 12.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2024 | Others | ₹0.97 M | Open |
| 19 Apr 2024 | Others | ₹0.90 M | Open |
| 25 Mar 2021 | Indian Bank | ₹19.39 Cr | Open |
| 30 Oct 2014 | Others | ₹12.00 Cr | Open |
| 18 Nov 2020 | Indian Bank | ₹4.00 Cr | Satisfied |
How Many Employees Work at Brooks Laboratories?
Brooks Laboratories has a workforce of 275 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brooks Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brooks Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
